Over past decades, nutritional and lifestyle habits, characterized by unbalanced ratio between high caloric intake and low caloric expenditure, have provided fertile ground for increasing prevalence of obesity that currently is one of the most important healthy and economic global problem (1).Huge data have demonstrated that dysregulated production of adipose secretome, triggered by unbalanced adipose tissue mass, leads to the development of non-communicable diseases, including diabetes, cardiovascular and respiratory disease, cognitive decline, and cancer. Since the discovery of leptin, the first adipokine identified in 1994, characterization of adipose secretome and its molecular mechanisms represents one of the most promising therapeutic weapons in the treatment of obesity and its correlated pathologies (2). As reported in this Research Topic by Chen P et al. an altered network of adipokines characterized polycystic ovary syndrome and influences all the different phases of menstrual cycle even if the underlying mechanisms needs to be clarified.
In conclusion, this Research Topic highlights the evolution of "adipose secretome" concept:thirty years ago, adipose secretome was a hypothesis, currently it is a fascinate and intricate and partly still mysterious network involved in several pathophysiological conditions, in future it will be a fundamental therapeutical target in the treatment of no-communicable diseases.

